About Us

At CareMetx, we are proud of our longstanding history in the patient advocacy space. From the very beginning, our focus has been deeply rooted in one common theme—that patients are the priority.

The roots of CareMetx trace back to the Cystic Fibrosis Foundation, founded in 1955 by parents and volunteers to raise awareness of cystic fibrosis. The foundation’s focus on patient advocacy and research grew significantly under the leadership of Bob Dresing, who became its first President and CEO in 1984. Bob later co-founded CareMetx alongside today’s Executive Chairman, Mark Hansan. Our CareMetx values have always been championed by leaders like Bob and Mark—dedicated individuals committed to advocating for patients and supporting manufacturers.

This history is one that continues to inspire the work we do. Our clients trust us because we fully grasp the enormous responsibility we assume on their behalf. We have helped manufacturers launch their very first product to market. We have helped clients transition single products or multiple franchises from underperforming vendors. We have helped customers deploy FDA-mandated Risk Evaluation and Mitigation Strategy programs. And above all, we have helped millions of patients get access to their medication faster. This longstanding history of patient support and stakeholder success speaks to why today’s clients trust us to continually innovate to find faster, smarter, better ways to serve their patients—and by doing so, to serve them.